Candriam S.C.A. Sanofi Transaction History

Candriam S.C.A.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$48.99 - $57.46 $1,126 - $1,321	-23 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$48.48 - $53.65 $1,115 - $1,233	23 New	23 $1,000
Q2 2021 Jul 20, 2021	SELL	$49.36 - $54.25 $3.46 Million - $3.8 Million	-70,048 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$45.46 - $50.51 $3,000 - $3,333	-66 Reduced 0.09%	70,048 $3.27 Million
Q4 2020 Jan 22, 2021	BUY	$45.3 - $51.62 $451,459 - $514,444	9,966 Added 16.57%	70,114 $3.41 Million
Q3 2020 Oct 19, 2020	BUY	$49.47 - $53.77 $441,074 - $479,413	8,916 Added 17.4%	60,148 $3.02 Million
Q2 2020 Jul 23, 2020	BUY	$42.91 - $52.5 $2.2 Million - $2.69 Million	51,212 Added 256060.0%	51,232 $2.62 Million
Q1 2020 May 26, 2020	BUY	$38.02 - $51.66 $760 - $1,033	20 New	20 $1,000
Q1 2019 May 02, 2019	SELL	$40.83 - $45.43 $1,265 - $1,408	-31 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$41.48 - $45.59 $41 - $45	-1 Reduced 3.13%	31 $1,000
Q3 2018 Nov 07, 2018	BUY	$40.0 - $44.84 $240 - $269	6 Added 23.08%	32 $1,000
Q2 2018 Aug 14, 2018	BUY	$37.63 - $41.22 $978 - $1,071	26 New	26 $1,000

819

274M

1.99M

1.87M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.